By TOM MURPHY, AAMER MADHANI and JONEL ALECCIA, Associated Press

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

Related Articles

Appeals court gives Trump another shot at erasing his hush money conviction

Trump has other tariff options if the Supreme Court strikes down his worldwide import taxes

At White House meeting, Hungary’s Orbán to seek Trump’s blessing to keep buying Russian oil

Nancy Pelosi won’t seek reelection, ending her storied career in the US House

Most major US airports are among 40 targeted by shutdown-related flight cuts

The drugs are part of a new generation of obesity medications known as GLP-1 receptor agoni

See Full Page